Syndax Pharmaceuticals, Inc. (SNDX)

Last Closing Price: 9.13 (2026-11-19)

Income after Taxes (Quarterly)

Income after Taxes: Earnings or losses after income tax expense but before minority interest, extraordinary items, discontinued operations, preferred dividends and accounting changes have been accounted for.

Syndax Pharmaceuticals, Inc. (SNDX) had Income after Taxes of $-49.43M for the most recently reported fiscal quarter, ending 2026-09-30.

Figures for fiscal quarter ending 2026-09-30
Income Statement Financials
$83.30M
$-49.43M
$14.00M
$69.30M
$125.19M
$-41.90M
$-7.54M
$-49.43M
$-49.43M
Income after Taxes
$-49.43M
$-49.43M
$-49.43M
$-49.43M
$-41.90M
$-43.30M
89.79M
89.79M
$-0.55
$-0.55
Balance Sheet Financials
$567.44M
$0.21M
$125.23M
$692.67M
$120.96M
$588.28M
$588.89M
$709.85M
$-17.18M
$-17.18M
$-17.18M
89.99M
Cash Flow Statement Financials
$-107.87M
$-155.00M
$263.88M
$135.03M
$136.04M
$1.01M
$41.35M
--
--
Fundamental Metrics & Ratios
4.69
--
--
1.03
-34.24
83.20%
-50.30%
-50.30%
--
-59.34%
-59.34%
$-107.91M
--
--
--
0.12
0.36
1.09
82.89
287.74%
287.74%
-7.14%
-8.66%
$-0.19
$-1.20
$-1.20